Skip to main content
TipRanks
Go Ultimate75% OFF

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Income Statement

9 Followers

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Income Statement

Last quarter (Q3 2026), Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's total revenue was HK$10.41B, an increase of 28.33% from the same quarter last year. In Q3, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's net income was HK$2.86B. See Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Mar 23Mar 22
HK$ 35.19BHK$ 29.77BHK$ 25.26BHK$ 24.23BHK$ 31.02B
HK$ 30.33BHK$ 25.68BHK$ 21.36BHK$ 20.26BHK$ 26.20B
HK$ 20.33BHK$ 17.71BHK$ 15.92BHK$ 15.58BHK$ 21.66B
Depreciation and AmortizationHK$ 924.26MHK$ 825.54MHK$ 779.89MHK$ 658.17MHK$ 651.70M
HK$ 10.63BHK$ 8.46BHK$ 5.95BHK$ 5.19BHK$ 5.19B
HK$ 10.00BHK$ 7.97BHK$ 5.43BHK$ 4.68BHK$ 4.54B
HK$ -314.14MHK$ -341.42MHK$ -268.73MHK$ -163.40MHK$ 845.48M
HK$ 9.69BHK$ 7.63BHK$ 5.17BHK$ 4.52BHK$ 5.38B
HK$ 8.58BHK$ 6.74BHK$ 4.76BHK$ 4.45BHK$ 5.46B
Per Share Metrics
Basic EPSHK$ 1.32HK$ 1.06HK$ 0.75HK$ 0.69HK$ 0.86
Diluted EPSHK$ 1.31HK$ 1.06HK$ 0.75HK$ 0.69HK$ 0.86
Weighted Average Shares Outstanding6.48B6.34B6.33B6.40B6.38B
Weighted Average Shares Outstanding (Diluted)6.53B6.34B6.33B6.40B6.38B

Currency in HKD

Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Earnings and Revenue History

015B30B45B16 %20 %24 %28 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin